Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07186088

Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies

To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tianjin Medical University Eye Hospital

Tianjin, Tianjin Municipality, 120120, China

Location contact

Guihua Liu

CONTACT

[email protected]

8686428756

About this study

The experiment will be divided into two phases. In the first phase, the subjects will be randomly grouped using laser equipment and LED equipment, and each group will be exposed to the red light twice a day for one month. The second stage involves self-comparison of the laser equipment, with the usage frequencies being once a day and three times a day.

To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light in different devices and frequencies, as well as its impact on the axial length, spherical equivalent refraction and choroidal thickness of myopia progression.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-35 years old, gender not limited; Obtained informed consent.

Exclusion criteria

  • Obvious strabismus and amblyopia
  • With congenital eye disease, such as congenital cataract, congenital retinal disease
  • Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
  • Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
  • Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
  • Bnormal intraocular pressure and clinical significance (IOP <10 mmHg or IOP>21mmHg or binocular IOP difference ≥5mmHg)
  • Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
  • Optic nerve damage or congenital optic nerve dysfunction
  • Can not be regularly checked
  • The adjustment range is less than 8D or obvious near difficulties
  • Other reasons researchers think it is not suitable for inclusion in researchers

Treatment and study plan

Eyerising RS-200-2A

Device

Eyerising RS-200-2A,1 time,2 times, 3 times a day

Airdoc Sky-n1201

Device

Eyerising RS-200-2A,2 times a day

Primary outcomes

  1. Axial length

    Time frame: From enrollment to the end of treatment up to 7 months

Secondary outcomes

  1. Spherical equivalent

    Time frame: From enrollment to the end of treatment up to 7 months

  2. Choroidal thickness

    Time frame: From enrollment to the end of treatment up to 7 months

Study contacts

Contact information is provided by the study sponsor or research team.

Guihua Liu

CONTACT

[email protected]

+8686428756

Sponsors and collaborators

Lead sponsor

Ruihua Wei

Other

Collaborators

  • Tianjin Medical University Eye Hospital

Registry information

Official study title

Study on the Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies for Adult Myopia Treatment

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 22, 2025
Registry last updated
Sep 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.